Bellicum Pharmaceuticals

Merrimack Pharmaceuticals

Merrimack Pharmaceuticals, Inc. (Nasdaq:MACK), is a biopharmaceutical company discovering, developing and preparing to commercialize innovative medicines paired with companion diagnostics for the treatment of serious diseases, with an initial focus on cancer.

Select Venture Capital & Financial Partners

Credit Suisse First Boston Crocker Ventures Jennison Associates Magnetar Capital LLC Next Fund Noonday Sorensen Development Unilever Technology Ventures Wharton Equity Partners